Chen, Ruidong
Liang, Xin
Murray, Mollianne M.
Karasik, Ellen
Han, Jenny J.
Zhu, Ming
Foster, Barbara A. http://orcid.org/0000-0003-0459-7011
Frigo, Daniel E. http://orcid.org/0000-0002-0713-471X
Wang, Guocan http://orcid.org/0000-0002-8922-7249
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P50 CA140388, R00CA194289, P30CA016056, P50 CA140388)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
American Cancer Society (RSG-16-084-01 — TBE)
Article History
Received: 5 July 2020
Revised: 20 August 2020
Accepted: 27 August 2020
First Online: 7 September 2020
Compliance with ethical standards
:
: DEF has received research funding from GTx, Inc and has a familial relationship with Maia Biotechnology, Alms Therapeutics, Hinova Pharmaceuticals and Barricade Therapeutics. The other authors report no potential conflicts of interest.